Soulen MC, Rilling WS. Clinical Outcomes After Personalized Dosimetry for (90)Y Radioembolization of Advanced Hepatocellular Carcinoma: Defining the Role of a Device in a Pharma-Centric Landscape. J Nucl Med 2024;65:270-271.
PMID: 38212067